Dr. Song’s research is focused on developing safer and more efficient AAV vectors for liver-target gene therapy. He is working on the evaluation of hepatotoxicity risks in 3D spheroids models for AAV gene therapy.

Assay Development, Drug Formulation, HPLC, Computational Modeling, Drug Delivery, Educational Research, PBPK Modeling, Pharmaceutical Policy, Pharmacogenomics, Pharmacokinetics, Pharmacy Practice, Precision Medicine

Assay Development, Bioanalytical Chemistry, Drug Formulation, Drug Quantification, LC-MS/MS, Aging, Cancer, Immunotherapy, Nanomedicine, Nanoparticle, Obesity, Pharmacokinetics, Precision Dosing, Precision Medicine

Assay Development, Chemical Libraries, Cheminformatics, Computational Drug Design, Machine Learning, Allosteric Modulators, Chemical Biology, Chemical Probes, Drug Discovery, Fragment Based Drug Design, Protein Kinase Inhibitors, Protein Kinases, Rare Diseases, Structure Activity Relationship, Synthetic Chemistry

Animal Models, Assay Development, Computational Drug Design, HPLC, LC-MS/MS, NMR Spectroscopy, X-ray Crystallography, Blood-brain Barrier, Cancer, Chemical Probes, Drug Discovery, Immunotherapy, Obesity, Pharmacokinetics, Protein Kinase Inhibitors, Structure Activity Relationship, Tumor Microenvironment

Assay Development, Chemical Libraries, Fluorescence Microscopy, HPLC, High Throughput Screening, LC-MS/MS, NMR Spectroscopy, Drug Delivery, Peptide Chemistry, Protein Kinases, Synthetic Chemistry